MedPath

Effect of Lavender in treatment of depression in diabetic patients

Not Applicable
Recruiting
Conditions
Condition 1: Depression. Condition 2: Diabetes Mellitus. Condition 3: Diabetes Mellitus.
Major Depressive Disorder, single episode, moderate
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Registration Number
IRCT20150309021386N2
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Type 1 or 2 diabetes mellitus that is controlled (70 <FBS <130 and 2hppG <180) • Age over 18 years old• Over 3-months history of depression based on Beck's questionnaire • Satisfaction with participating in the study • No usage of out-of-study protocol treatments (all anti-depressant drugs (TCA, SSRI, SNRI, etc.) and medicinal herbs affecting mood such as bell peppermint, valerian fever, and lemon balm, etc.) • Patients who have mild to moderate depression based on the Beck criteria (score less than 28)

Exclusion Criteria

Pregnancy, Lactation, Systemic unstable diseases (liver, thyroid, cardiovascular, renal dx), Active suicidal thoughts

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Beck Depression Inventory Score. Timepoint: At The Beginning And at The End of The Study. Method of measurement: Beck Depression Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Pittsburgh Insomnia Questionnaire. Timepoint: At The Beginning and at The End of The Study. Method of measurement: Pittsburgh Insomnia Questionnaire.;Change of WHO-5 Well-being Index Questionnaire Score. Timepoint: At The Beginning and at The End of The Study. Method of measurement: WHO-5 Well-being Index Questionnaire.;Change of Biochemical Variables. Timepoint: At The Beginning and at The End of The Study. Method of measurement: Laboratory Data.
© Copyright 2025. All Rights Reserved by MedPath